Nuformix Media (NFX)
NFX Share
NFX Share
NFX Share
NFX Share
NFX
NFX Share
NFX Level 2
NFX Live
NFX Broker
NFX Directors
NFX Financial
NFX
NFX Short
NFX
NFX Company
NFX Company
Last checked at -
Nuformix plc ( NFX ) reports audited results for the year ended 30 September 2025, highlighting progress across its drug repurposing pipeline in fibrosis and oncology. The Company’s lead programme,...
Which company is considering spinning off the jewel in the crown while another veteran stock is not jiving with more recent trends, and which business had another successful stock market debut? ...
Nuformix (LON:NFX) targets unmet medical needs in fibrosis and oncology via drug repurposing. The pharmaceutical company’s lead programme NXP002 has been granted Orphan Drug Designation in Idiopa...
Sign In
Last checked at 
Follow the stocks
